ClinicalTrials.gg
RecruitingNCT07927296Updated Nov 10, 2026

Vinegar and Heartburn

An interventional study of Vinegar and vinegar pill in Heartburn, sponsored by Arizona State University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Arizona State University · Not applicable, Interventional, and Prevention

Updated Nov 10, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this study, a popular home remedy, vinegar, will be tested for its efficacy to relieve the discomfort of heartburn possibly by inducing the esophageal clearing mechanisms. We plan to recruit 22 individuals who report regular heartburn, but not diagnosed with erosive reflux disease, for this randomized crossover trial. Enrolled participants will identify foods that consistently cause their heartburn, and two of these foods will be prepared and consumed during their visits. Participants will arrive at the testing center on two occasions following a 4-h fast (no food or beverage except water) and consume the targeted foods in a 10-minute period. On one visit liquid vinegar will be ingested with the meal, and on the other visit (order of visits will be randomly determined) a vinegar tablet (control) will be ingested with the meal. Starting prior to food ingestion and for 2 hours post meal, symptoms will be assessed at 10-to-15-minute intervals by the participant using a validated heartburn severity scale.

Read the detailed description

Currently a great deal of research is focused on relationships between GERD, esophageal pH, esophageal clearing-content mechanisms, and the functioning of the esophageal sphincter (LES). Transient LES relaxation may also contribute to GERD. In the esophagus, both chemical and physical reactions are used to clear content from the stomach due to reflux. Saliva flow is increased when the body senses acid because saliva acts as a buffer, which neutralizes the acid through chemical reactions. The physical process of clearing acidic content occurs via esophageal emptying by peristalsis. Several studies show that, in the esophageal mucosa, there are acid sensitive receptors that sense the change in intraluminal pH and induce esophageal peristaltic contractions that are independent of swallowing. The movement of this acid-induced contraction is long in duration, high in amplitude, and low in propagation velocity. As the first randomized controlled trial examining the effect of vinegar ingestion on heartburn, this study will examine symptoms of heartburn only and not focus on mechanisms.

02

Conditions studied

  • Heartburn

Browse trials for

Keywords

  • vinegar
  • heartburn
03

In context

Heartburn

154 studies on the registry are indexed under Heartburn; 12 are open to participants now.

This study's planned enrollment of 22 is below the median of 100 across 127 interventional studies indexed under Heartburn.

Browse Heartburn studies →

Lead sponsor

Arizona State University is the lead sponsor of 238 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • report heartburn symptoms two or more times a week for several weeks or months
  • Any over the counter PPI use (proton-pump inhibitors such as Prilosec, Nexium, Prevacid) will need to be restricted for one month.

Exclusion criteria

Exclusion Criteria:

  • Drug use (prescription, over-the-counter, or otherwise) known to affect the stomach and digestive processes, including GLP-1 RA or GLP/GIP medications
  • Medical conditions that impact normal functioning of the gastrointestinal tract (e.g., Crohn's disease, Celiac disease, short bowel syndrome, ostomy, lactose intolerance, hernia , SIBO, H. Pylori positive hasn't been cleared etc.).
  • Excess alcohol use (>2 servings daily)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
22 participants (estimated)

Study arms

  • Experimental
    Vinegar drink

    2 tablespoons apple cider vinegar

    Dietary Supplement: Vinegar

  • Placebo comparator
    Placebo

    Vinegar tablet

    Dietary Supplement: vinegar pill

Interventions

  • Dietary supplementVinegar

    2 Tablespoons

  • Dietary supplementvinegar pill

    Tablet

06

What researchers measure

Primary outcomes

  1. heartburn symptoms

    validated Likert scale questionnaires

    Time frame: measured premeal and at 15 to 30 minute intervals during the 2-h postprandial period

07

Study locations

1 of 1 sites recruiting
  • Arizona Biomedical Collaborative
    Phoenix, Arizona 85004, United States
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for May 2027, 5 months later.

Of 26 interventional studies with no phase under Heartburn, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 35. This study's planned 5 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 10, 2026
StartEst.
Nov 16, 2026
Primary completionEst.
May 15, 2027
CompletionEst.
May 15, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07927296
Responsible party
Carol Johnston (Professor and Sr. Associate Dean, Arizona State University) — Principal investigator
First posted
Nov 10, 2026
Start date
Nov 16, 2026 (estimated)
Primary completion
May 15, 2027 (estimated)
Completion
May 15, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Carol Johnston, PhD
Contact
carol.johnston@asu.edu
6024963463

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Acetic Acid

Start the discussion